Literature DB >> 17553589

Stability of lipid excipients in solid lipid nanoparticles.

Anna Radomska-Soukharev1.   

Abstract

The paper is devoted to the investigation of chemical stability of lipids used as excipients in the production of Solid Lipid Nanoparticles (SLN). Different lipids and amounts of surfactants were considered. Most of the formulations were produced using identical binary surfactant mixtures and concentrations to analyze the effect of the chemical nature of the lipids on their stability in SLN. In some formulations, surfactants were exchanged or their concentration was increased to assess the contribution of surfactants on stability of lipids particles. Solid Lipid Nanoparticles were characterized by photon correlation spectroscopy, laser diffractometry, zeta potential determination and differential scanning calorimetry. Potential effects of lipid crystallinity and modifications were assessed. A gas chromatography (GC) analysis in combination with a method for lipid extraction from aqueous SLN dispersions was used to investigate the chemical stability of the lipid excipients forming the particle matrix. All formulations were produced by the hot homogenization technique. The production process of SLN itself did not affect the chemical stability of lipid excipient forming the particle matrix. The formulations where lipids consisted of trigylicerides showed a negligible decomposition of the structure during incubation at 25 degrees C. Dynasan 118 showed the highest chemical stability (loss<4%) within two years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553589     DOI: 10.1016/j.addr.2007.04.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  22 in total

1.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

Review 2.  Membrane-core nanoparticles for cancer nanomedicine.

Authors:  Jianfeng Guo; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-22       Impact factor: 15.470

Review 3.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

4.  Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

Authors:  Ping Ma; Xiaowei Dong; Courtney L Swadley; Anshul Gupte; Markos Leggas; Harry C Ledebur; Russell J Mumper
Journal:  J Biomed Nanotechnol       Date:  2009-04       Impact factor: 4.099

5.  Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation.

Authors:  Ebru Başaran
Journal:  Turk J Pharm Sci       Date:  2017-08-15

6.  Levocetirizine Dihydrochloride-Loaded Chitosan Nanoparticles: Formulation and In Vitro Evaluation.

Authors:  Gülsel Yurtdaş Kirimlioğlu; A Alper Öztürk
Journal:  Turk J Pharm Sci       Date:  2020-02-19

7.  Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions.

Authors:  Michael H Chiu; Elmar J Prenner
Journal:  J Pharm Bioallied Sci       Date:  2011-01

8.  Lipid nanocapsule-based gels for enhancement of transdermal delivery of ketorolac tromethamine.

Authors:  Jaleh Varshosaz; Valiollah Hajhashemi; Sindokht Soltanzadeh
Journal:  J Drug Deliv       Date:  2011-11-17

9.  Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.

Authors:  Yosra S R Elnaggar; Magda A El-Massik; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2011-12-06

10.  Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles.

Authors:  Hossein Ali Ebrahimi; Yousef Javadzadeh; Mehrdad Hamidi; Mohammad Barzegar Jalali
Journal:  Daru       Date:  2015-09-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.